Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Aclaris Therapeutics (ACRS) Long-Term Debt Issuances (2020)

Aclaris Therapeutics has reported Long-Term Debt Issuances over the past 1 years, most recently at -$37000.0 for Q2 2020.

  • Quarterly results put Long-Term Debt Issuances at -$37000.0 for Q2 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $10.9 million (changed N/A YoY), and the annual figure for FY2020 was $10.9 million, changed.
  • Long-Term Debt Issuances for Q2 2020 was -$37000.0 at Aclaris Therapeutics, down from $11.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for ACRS hit a ceiling of $11.0 million in Q1 2020 and a floor of -$37000.0 in Q2 2020.